Evenamide

Evenamide (NW-3509) is an orally available voltage-gated sodium channel (VGSC) blocker (Ki=0.4 µM) for the research of schizophrenia. Evenamide shows efficacy in a broad spectrum of rodent models of psychosis, mania, depression, and aggressiveness.


Cat. No.: EX-A9007	Purity: >98%

	Chemical structure of Evenamide

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
250mg	get quote	In-stock
500mg	get quote	In-stock
1g	get quote	In-stock
2g	get quote	In-stock
5g	get quote	In-stock
10g	get quote	Inquire

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


Synonyms	NW-3509
CAS No.	1092977-61-1
Purity	>98%
Formula	C16H26N2O2
Mol Weight	278.3898
Appearance	Colorless to light yellow liquid
Solubility	Soluble in DMSO >50 mg/mL;
Shelf Life	>2 years if stored properly
Storage	Pure form -20℃ 3 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Valentina Zuliani, et al. Advances in Design and Development of Sodium Channel Blockers. Ion Channels and Their Inhibitors pp 79-115. [2]. Faravelli, et al. P.3.f.022 Evenamide (formerly NW-3509) targets new mechanisms, and represents a new approach to the management of untreated symptoms in schizophrenia.
CoA	CoA of Evenamide

Smiles:	O=C(N(C)C)CNCCC1=CC=CC(OCCCC)=C1


		Search